Shamez N Ladhani1, Kazim Beebeejaun2, Jay Lucidarme3, Helen Campbell2, Steve Gray3, Ed Kaczmarski3, Mary E Ramsay2, Ray Borrow3. 1. Immunisation Department, Public Health England Paediatric Infectious Diseases Research Group, St George's University of London. 2. Immunisation Department, Public Health England. 3. Meningococcal Reference Unit, Public Health England, Manchester Medical Microbiology, Manchester Royal Infirmary, United Kingdom.
Abstract
BACKGROUND: In England and Wales, the incidence of invasive meningococcal disease has been declining for more than a decade, but meningococcal group W (MenW) cases have been increasing since 2009. METHODS: Public Health England conducts enhanced national surveillance of invasive meningococcal disease in England and Wales. Detailed clinical information was obtained for all laboratory-confirmed MenW cases diagnosed during 3 epidemiologic years (2010-2011 to 2012-2013), alongside whole-genome sequencing analysis of the clinical isolates. RESULTS: The year-on-year increase in invasive MenW disease across all age groups since 2009-2010 was due to rapid endemic expansion of a single clone belonging to the sequence type 11 complex (cc11). In 2013-2014, MenW was responsible for 15% of all invasive meningococcal disease. All but 1 of the recent MenW:cc11 isolates were very closely related, consistent with recent clonal expansion. Clinical follow-up of all 129 MenW cases diagnosed during 2010-2011 to 2012-2013 revealed that most patients were previously healthy (n = 105 [81%]), had not travelled abroad prior to illness and the majority presented with septicemia (n = 63 [49%]), meningitis (n = 16 [12%]) or both (n = 21 [16%]); however, one-quarter had atypical presentations including pneumonia (n = 15 [12%]), septic arthritis (n = 9 [7%]), and epiglottitis/supraglottitis (n = 5 [4%]). Forty-eight (37%) required intensive care and 15 (12%) died. There was no association between infecting strain, clinical disease, or outcome. CONCLUSIONS: The recent increase in invasive MenW disease in England and Wales is due to rapid endemic expansion of a single clone belonging to cc11 and is associated with severe disease with unusual clinical presentations. This increase will require careful monitoring in the coming years.
BACKGROUND: In England and Wales, the incidence of invasive meningococcal disease has been declining for more than a decade, but meningococcal group W (MenW) cases have been increasing since 2009. METHODS: Public Health England conducts enhanced national surveillance of invasive meningococcal disease in England and Wales. Detailed clinical information was obtained for all laboratory-confirmed MenW cases diagnosed during 3 epidemiologic years (2010-2011 to 2012-2013), alongside whole-genome sequencing analysis of the clinical isolates. RESULTS: The year-on-year increase in invasive MenW disease across all age groups since 2009-2010 was due to rapid endemic expansion of a single clone belonging to the sequence type 11 complex (cc11). In 2013-2014, MenW was responsible for 15% of all invasive meningococcal disease. All but 1 of the recent MenW:cc11 isolates were very closely related, consistent with recent clonal expansion. Clinical follow-up of all 129 MenW cases diagnosed during 2010-2011 to 2012-2013 revealed that most patients were previously healthy (n = 105 [81%]), had not travelled abroad prior to illness and the majority presented with septicemia (n = 63 [49%]), meningitis (n = 16 [12%]) or both (n = 21 [16%]); however, one-quarter had atypical presentations including pneumonia (n = 15 [12%]), septic arthritis (n = 9 [7%]), and epiglottitis/supraglottitis (n = 5 [4%]). Forty-eight (37%) required intensive care and 15 (12%) died. There was no association between infecting strain, clinical disease, or outcome. CONCLUSIONS: The recent increase in invasive MenW disease in England and Wales is due to rapid endemic expansion of a single clone belonging to cc11 and is associated with severe disease with unusual clinical presentations. This increase will require careful monitoring in the coming years.
Authors: Henju Marjuki; Nadav Topaz; Lorraine D Rodriguez-Rivera; Edward Ramos; Caelin C Potts; Alexander Chen; Adam C Retchless; Gregory H Doho; Xin Wang Journal: J Clin Microbiol Date: 2019-02-27 Impact factor: 5.948
Authors: Rsw Tsang; L Hoang; G J Tyrrell; G Horsman; P Van Caeseele; F Jamieson; B Lefebvre; D Haldane; R R Gad; G J German; G Zahariadis Journal: Can Commun Dis Rep Date: 2017-07-06
Authors: Michael Bröker; Stéphane Emonet; Cecilia Fazio; Susanne Jacobsson; Maria Koliou; Markku Kuusi; David Pace; Metka Paragi; Alexander Pysik; Maria João Simões; Anna Skoczynska; Paola Stefanelli; Maija Toropainen; Muhamed-Kheir Taha; Georgina Tzanakaki Journal: Hum Vaccin Immunother Date: 2015 Impact factor: 3.452